Adiposity and ischaemic Heart Disease in the UK Biobank: A prospective cohort study of 450 000 adults.
Adiposity and ischaemic Heart Disease in the UK Biobank: A prospective cohort study of 450 000 adults.
批准号:
1808955
负责人:
金额:
$0.0万
依托单位:
依托单位国家:
英国
项目类别:
Studentship
财政年份:
2016
资助国家:
英国
项目状态:
已结题
起止时间:
2016 至 --
中文摘要
背景:2010年,缺血性心脏病(IHD)是全球死亡和每日调整生命年损失的主要原因。肥胖越来越被认为是心血管疾病(CVD)的主要危险因素,包括IHD。肥胖导致心血管疾病的机制被认为部分是由于其对血脂异常、高血压和糖尿病等血管危险因素的不利影响。然而,高肥胖水平的一些额外风险仍未得到解释。重要的是,随着全球平均BMI每十年增加约1.5kg/m2,以及全球IHD死亡人数的增加,开展高质量的研究,对当代人群中与肥胖相关的IHD风险进行详细估计,具有至关重要的意义。目前,关于肥胖和心血管疾病之间关联的最可靠的估计来自前瞻性研究的汇总分析,例如前瞻性研究合作。然而,这些荟萃分析仅限于致命事件,与单一研究相比,无法对混杂因素进行详细的评估。此外,大多数参与者是30-40年前招募的,这些发现与当前英国人口的相关性尚不清楚。重要的是,常用的肥胖测量方法,如腰臀比(WHR)、腰围和身体质量指数(BMI)是有用的,但不完美的身体脂肪测量方法。研究UKB参与者的一个优势是生物阻抗的可用性,这是一种潜在的更有信息的肥胖测量方法,因为它提供了相对于体重的总体和局部体脂的估计。然而,生物阻抗与IHD风险之间的关系尚未在大型和强大的流行病学研究中进行调查。UKB的另一个优势是使用高精度双能x射线吸收仪(DEXA)和磁共振成像(MRI)对10万名参与者的肥胖进行持续直接测量。这将使在估计人口亚组的一般和中心肥胖时评估每个肥胖测量的可靠性成为可能。i)肥胖和IHD:前瞻性关联——调查50万UKB参与者腰围、腰宽比、BMI和生物阻抗与IHD事件(致命和非致命)风险的关系。估计将根据吸烟、年龄和性别等重要的潜在混杂因素进行调整。此外,所有估计都将酌情校正回归稀释偏差;使用调查数据来评估肥胖测量的个人变异性。-确定在该人群和重要人群亚组中对IHD事件风险最有预测价值的肥胖测量方法。ii)横断面关联-根据地理位置和各种其他个体参与者特征,研究UKB队列人群中不同亚组的肥胖分布。-描述肥胖测量与已知和潜在中间因素(包括糖尿病、血压和脂质水平)之间的横断面关联。-调查不同肥胖指标之间的相关性,特别强调通过DEXA和MRI扫描评估的肥胖指标与体脂分布之间的关系。iii)遗传分析:-利用全基因组分析的信息来研究与不同肥胖测量和身体成分估计相关的SNP模式。随后生成肥胖的个体遗传评分,并调查这些遗传评分与IHD发病风险的相关风险。
英文摘要
BackgroundIschaemic heart disease (IHD) was the leading cause of death and Daily Adjusted Life Years lost to disability worldwide in 2010. Adiposity is becoming increasingly recognized as a leading risk factor for cardiovascular disease (CVD), including IHD. The mechanism through which adiposity causes CVD is thought to be the result, in part, of its adverse effect on well-established vascular risk factors such as dyslipidemia, hypertension and diabetes mellitus. However, some of the excess risk at high levels of adiposity remains unexplained. Importantly, with the global average BMI increasing by around 1.5kg/m2 each decade and with IHD deaths rising worldwide, it is of fundamental importance to conduct high-quality research delivering detailed estimates of the risk of IHD associated with adiposity in contemporary populations. Currently, the most robust estimates of the association between adiposity and CVD are derived from pooled analyses of prospective studies, such as the Prospective Studies Collaboration. However, these meta-analyses were restricted to fatal events, and could not conduct as detailed an assessment of confounding compared to a single study. Furthermore, most participants were recruited 30-40 years ago, and the relevance of these findings to the current UK population is unclear. Importantly, commonly used measures of adiposity such as waist-to-hip ratio (WHR), waist circumference and BMI are useful but imperfect measures of body fat. An advantage of studying UKB participants is the availability of bio-impedance, a potentially more informative measure of adiposity, as it provides an estimate of total and regional body fat relative to body weight. However, the association between bio-impedance and IHD risk has yet to be investigated in large and robust epidemiological studies. A further advantage of UKB is the on-going direct measurement of adiposity in 100 000 participants using highly accurate dual energy X-ray absorptiometry (DEXA) and magnetic resonance imaging (MRI). This will enable the assessment of the reliability of each adiposity measure when estimating general and central adiposity in population sub-groups. Aims i) Adiposity and IHD: Prospective associations- Investigating the association of waist circumference, WHR, BMI and bio-impedance with risk of incident IHD events (both fatal and non-fatal) in 500, 000 UKB participants. Estimates will be adjusted for important potential confounders such as smoking, age and sex. Furthermore, all estimates will be corrected, where appropriate, for regression dilution bias; using resurvey data to assess within-person variability of adiposity measures.- Identifying the adiposity measure with the most predictive value for incident IHD risk in this population and across important sub-groups of the population.ii) Cross-sectional associations - Studying the distribution of adiposity across sub-groups of the UKB cohort population, according to geographical location and various other individual participant characteristics. - Describing cross-sectional associations between measures of adiposity with known and potential intermediate factors, including diabetes mellitus, blood pressure and lipid levels.- Investigating correlations between different adiposity measures, with particular emphasis on the relationship between adiposity measures and body fat distribution as assessed by DEXA and MRI scans. iii) Genetic analysis:- Using information from genome-wide assays to investigate patterns of SNP's associated with different adiposity measures and body composition estimates. Subsequently generating individual genetic scores for adiposity, and investigating the associated risk of these genetic scores for risk of IHD incidence.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
海外基金